RNA Therapeutics Institute

RNA Therapeutics Institute Dedicated to leveraging the strong RNA biology and clinical research communities to develop novel therapies for which RNA is the therapeutic target.

10/07/2024

Congratulations to our 2024 medicine laureate Victor Ambros ✨

This morning he celebrated the news of his prize with his colleague and wife Rosalind Lee, who was also the first author on the 1993 'Cell' paper cited by the Nobel Committee.

Join us today to find out more about the UMass Chan Early Independence Fellows Program! Today, Oct. 2, at 4pm, register ...
10/02/2024

Join us today to find out more about the UMass Chan Early Independence Fellows Program! Today, Oct. 2, at 4pm, register here to attend: https://direc.to/mktA

12/07/2023
Elizabeth M.C. Hillman will present the 22nd Fredric S. Fay Memorial Lecture, Capturing the dynamics of life with high-...
09/26/2023

Elizabeth M.C. Hillman will present the 22nd Fredric S. Fay Memorial Lecture, Capturing the dynamics of life with high-speed 3D microscopy on October 11th at 3pm & via Zoom with reception to follow. For more info including zoom links: https://bit.ly/3rtZ0Lj

Join us to celebrate the Life, Impact, and Legacy of Dr. Michael R. Green with a scientific symposium in his honor on Tu...
09/26/2023

Join us to celebrate the Life, Impact, and Legacy of Dr. Michael R. Green with a scientific symposium in his honor on Tuesday, October 10, 2023! Open to all, but please register as limited seats are available: https://bit.ly/3tbqGoP

📢 Calling all undergrads! 📢 , , , & are hosting a career day & we want YOU to join us Oct 17 to hear why MA is among t...
09/25/2023

📢 Calling all undergrads! 📢 , , , & are hosting a career day & we want YOU to join us Oct 17 to hear why MA is among the fastest growing states for biotech careers! Register: https://bit.ly/3LAfJ6u

05/21/2023

MD/PhD student Jillian Belgrad has received an award from the National Institute of Neurological Disorders and Stroke to study the pathology that drives the development of Huntington’s disease symptoms.  

Have you registered for the 5th annual RNA Therapeutics: From Concept to Clinic Symposium yet? Early bird registration ...
04/12/2023

Have you registered for the 5th annual RNA Therapeutics: From Concept to Clinic Symposium yet? Early bird registration is closing shortly! Register today: https://bit.ly/3MBL0Y0

Address

368 Plantation St
Worcester, MA
01605

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when RNA Therapeutics Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RNA Therapeutics Institute:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About Us

Who we are

The RTI was founded in 2009 and became an academic department in 2016, chaired by Phillip D. Zamore, Ph.D. The RTI is dedicated to leveraging the strong RNA biology and clinical research communities at UMMS to develop novel therapies for which RNA is the therapeutic target or modality. The RNA Therapeutics Institute faculty are recognized as scientific trailblazers, and include a Nobel Laureate, a Gairdner Prize recipient, the 2018 RNA Society early and mid-career award recipients, and two Howard Hughes Medical Institute Investigators.

The RTI comprises a key component of the UMMS Advanced Therapeutics Cluster, which also includes the Neurotherapeutics Institute and the Gene Therapy Center. The Neurotherapeutics Institute is co-directed by RTI faculty members Melissa Moore, Ph.D., and Neil Aronin, M.D., along with Robert Brown, M.D., D. Phil., who chairs the Department of Neurology. The RTI’s close affiliation with the Neurotherapeutics Institute and the Gene Therapy Center provides an unparalleled intellectual environment in which to accomplish the common goal of developing novel therapeutics.

What we do